The PRISMA 2020 statement: an updated guideline for reporting systematic reviews - PubMed (original) (raw)

Joanne E McKenzie 2, Patrick M Bossuyt 3, Isabelle Boutron 4, Tammy C Hoffmann 5, Cynthia D Mulrow 6, Larissa Shamseer 7, Jennifer M Tetzlaff 8, Elie A Akl 9, Sue E Brennan 2, Roger Chou 10, Julie Glanville 11, Jeremy M Grimshaw 12, Asbjørn Hróbjartsson 13, Manoj M Lalu 14, Tianjing Li 15, Elizabeth W Loder 16, Evan Mayo-Wilson 17, Steve McDonald 2, Luke A McGuinness 18, Lesley A Stewart 19, James Thomas 20, Andrea C Tricco 21, Vivian A Welch 22, Penny Whiting 18, David Moher 23

Affiliations

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J Page et al. BMJ. 2021.

Abstract

The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/conflicts-of-interest/ and declare: EL is head of research for the BMJ; MJP is an editorial board member for PLOS Medicine; ACT is an associate editor and MJP, TL, EMW, and DM are editorial board members for the Journal of Clinical Epidemiology; DM and LAS were editors in chief, LS, JMT, and ACT are associate editors, and JG is an editorial board member for Systematic Reviews. None of these authors were involved in the peer review process or decision to publish. TCH has received personal fees from Elsevier outside the submitted work. EMW has received personal fees from the American Journal for Public Health, for which he is the editor for systematic reviews. VW is editor in chief of the Campbell Collaboration, which produces systematic reviews, and co-convenor of the Campbell and Cochrane equity methods group. DM is chair of the EQUATOR Network, IB is adjunct director of the French EQUATOR Centre and TCH is co-director of the Australasian EQUATOR Centre, which advocates for the use of reporting guidelines to improve the quality of reporting in research articles. JMT received salary from Evidence Partners, creator of DistillerSR software for systematic reviews; Evidence Partners was not involved in the design or outcomes of the statement, and the views expressed solely represent those of the author.

Figures

Fig 1

Fig 1

PRISMA 2020 flow diagram template for systematic reviews. The new design is adapted from flow diagrams proposed by Boers, Mayo-Wilson et al. and Stovold et al. The boxes in grey should only be completed if applicable; otherwise they should be removed from the flow diagram. Note that a “report” could be a journal article, preprint, conference abstract, study register entry, clinical study report, dissertation, unpublished manuscript, government report or any other document providing relevant information.

Comment in

Similar articles

References

    1. Gurevitch J, Koricheva J, Nakagawa S, Stewart G. Meta-analysis and the science of research synthesis. Nature 2018;555:175-82. . 10.1038/nature25753 - DOI - PubMed
    1. Gough D, Thomas J, Oliver S. Clarifying differences between reviews within evidence ecosystems. Syst Rev 2019;8:170. . 10.1186/s13643-019-1089-2 - DOI - PMC - PubMed
    1. Moher D. Reporting guidelines: doing better for readers. BMC Med 2018;16:233. . 10.1186/s12916-018-1226-0 - DOI - PMC - PubMed
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264-9, W64. 10.7326/0003-4819-151-4-200908180-00135 - DOI - PubMed
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535. 10.1136/bmj.b2535 - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources